Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

DEXCOM, INC.

(DXCM)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/20/2020 10/21/2020 10/22/2020 10/23/2020 10/26/2020 Date
392.43(c) 387.84(c) 395.795(c) 411(c) 418 Last
814 754 764 008 464 495 548 242 894 836 Volume
-1.28% -1.17% +2.05% +3.84% +1.70% Change
More quotes
Financials (USD)
Sales 2020 1 874 M - -
Net income 2020 175 M - -
Net Debt 2020 132 M - -
P/E ratio 2020 230x
Yield 2020 -
Sales 2021 2 304 M - -
Net income 2021 285 M - -
Net cash position 2021 354 M - -
P/E ratio 2021 142x
Yield 2021 -
Capitalization 39 350 M 39 350 M -
EV / Sales 2020 21,1x
EV / Sales 2021 16,9x
Nbr of Employees 3 900
Free-Float 98,8%
More Financials
Company
DexCom, Inc. specialises in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 78.7% of net sales. 
More about the company
Notations Surperformance© of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about DEXCOM, INC.
05:26pDEXCOM INC : Results of Operations and Financial Condition, Change in Directors ..
AQ
04:43pDEXCOM : Announces Retirement of Rick Doubleday and Pre-Announcement of Third Qu..
BU
10/23Covid-19 Continues to Boost and Bust S&P 500 Companies
DJ
10/22DEXCOM, INC. : quaterly earnings release
10/13DEXCOM INC : Change in Directors or Principal Officers, Other Events, Financial ..
AQ
10/13DEXCOM : Appoints Kyle Malady to Board of Directors
BU
10/08ELI LILLY AND COMPANY : - Lilly and Dexcom team up on new program to help improv..
AQ
10/07DEXCOM : Lilly and Dexcom team up on new program to help improve diabetes manage..
PR
10/01DEXCOM SCHEDULES THIRD QUARTER 2020 : 30 p.m. Eastern Time.
BU
09/24DEXCOM : Signs Multi-Year Collaboration Agreement with the University of Virgini..
BU
09/22DEXCOM : G6 Continuous Glucose Monitoring System Now Available at Veterans Affai..
BU
09/16DEXCOM : Announces First-Ever Registry Dedicated to Tracking Outcomes of In-Hosp..
BU
09/15DEXCOM : US' Dexcom to open services centre in Vilnius in 2021
AQ
09/09DEXCOM INC : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fi..
AQ
09/04DEXCOM : Announces Upcoming Virtual Conference Presentations
BU
More news
News in other languages on DEXCOM, INC.
10/22DEXCOM, INC. : Veröffentlichung des Quartalsergebnisses
10/22DEXCOM, INC. : publication des résultats trimestriels
07/23DEXCOM, INC. : Veröffentlichung des Halbjahresergebnisses
07/23DEXCOM, INC. : publication des résultats semestriels
05/07WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
More news
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 457,26 $
Last Close Price 411,00 $
Spread / Highest target 31,4%
Spread / Average Target 11,3%
Spread / Lowest Target -49,6%
EPS Revisions
Managers
NameTitle
Kevin Ronald Sayer Chairman, President & Chief Executive Officer
Quentin S. Blackford Chief Operating & Financial Officer
Andrew K. Balo EVP-Clinical Affairs, Regulatory Strategies
Jacob Leach Chief Technology Officer & Executive VP
Shelly R. Selvaraj Senior Vice President-Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.87.89%39 350
ABBOTT LABORATORIES24.10%190 845
MEDTRONIC PLC-1.79%149 794
BECTON, DICKINSON AND COMPANY-11.65%69 650
HOYA CORPORATION12.78%42 617
BAXTER INTERNATIONAL INC.-3.03%41 050